13-Cis Retinoic Acid (Aerosolized)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 13-Cis Retinoic Acid (Aerosolized), covering 2021-10-14 to 2021-10-14. Get the full timeline:
Most recent: Clinical Trial Update: Utilizing the Crosstalk Among Chicoric Acid, 13-Cis Retinoic Acid(Aerosolized), Minocycline and Vitamin D as a Potent Quadrate Therapy for Treating Patients With Multidrug-resistant TB and Patient With Both Multidrug-resistant TB and COVID-19 [Phase 2]